99 related articles for article (PubMed ID: 2484702)
21. Stimulatory and inhibitory action of nitric oxide donor agents vs. nitrovasodilators on reactive oxygen production by isolated polymorphonuclear leukocytes.
Pieper GM; Clarke GA; Gross GJ
J Pharmacol Exp Ther; 1994 May; 269(2):451-6. PubMed ID: 8182511
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide regulates the calcium current in isolated human atrial myocytes.
Kirstein M; Rivet-Bastide M; Hatem S; Bénardeau A; Mercadier JJ; Fischmeister R
J Clin Invest; 1995 Feb; 95(2):794-802. PubMed ID: 7860763
[TBL] [Abstract][Full Text] [Related]
24. Nitric oxide and effects of cationic polypeptides in canine cerebral arteries.
Kinoshita H; Katusic ZS
J Cereb Blood Flow Metab; 1997 Apr; 17(4):470-80. PubMed ID: 9143230
[TBL] [Abstract][Full Text] [Related]
25. Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.
Gruetter CA; Gruetter DY; Lyon JE; Kadowitz PJ; Ignarro LJ
J Pharmacol Exp Ther; 1981 Oct; 219(1):181-6. PubMed ID: 6270297
[TBL] [Abstract][Full Text] [Related]
26. Neurogenic and non-neurogenic relaxations caused by nicotine in isolated dog superficial temporal artery.
Okamura T; Enokibori M; Toda N
J Pharmacol Exp Ther; 1993 Sep; 266(3):1416-21. PubMed ID: 8396635
[TBL] [Abstract][Full Text] [Related]
27. Relative potency and arteriovenous selectivity of nitrovasodilators on human blood vessels: an insight into the targeting of nitric oxide delivery.
MacAllister RJ; Calver AL; Riezebos J; Collier J; Vallance P
J Pharmacol Exp Ther; 1995 Apr; 273(1):154-60. PubMed ID: 7714761
[TBL] [Abstract][Full Text] [Related]
28. Endothelium-dependent vasodilatation in human epicardial coronary arteries: effect of prolonged exposure to glyceryl trinitrate or SIN-1.
Kuhn M; Förstermann U
J Cardiovasc Pharmacol; 1989; 14 Suppl 11():S47-54. PubMed ID: 2484699
[TBL] [Abstract][Full Text] [Related]
29. Effects of 2-nicotinamidoethyl nitrate (nicorandil; SG-75) and its derivative on smooth muscle cells of the canine mesenteric artery.
Inoue T; Kanmura Y; Fujisawa K; Itoh T; Kuriyama H
J Pharmacol Exp Ther; 1984 Jun; 229(3):793-802. PubMed ID: 6233418
[TBL] [Abstract][Full Text] [Related]
30. Effects of naftidrofuryl on adrenergic nerves, endothelium and smooth muscle in isolated canine blood vessels.
Zander JF; Aarhus LL; Katusic ZS; Rubanyi GM; Vanhoutte PM
J Pharmacol Exp Ther; 1986 Dec; 239(3):760-7. PubMed ID: 3025417
[TBL] [Abstract][Full Text] [Related]
31. Differential effects of nitrovasodilators and nitric oxide on porcine tracheal and bronchial muscle in vitro.
Stuart-Smith K; Bynoe TC; Lindeman KS; Hirshman CA
J Appl Physiol (1985); 1994 Sep; 77(3):1142-7. PubMed ID: 7836115
[TBL] [Abstract][Full Text] [Related]
32. CAS 936, a novel syndnonimine with direct vasodilating and nitric oxide-donating properties: effects on isolated blood vessels.
Bohn H; Beyerle R; Martorana PA; Schönafinger K
J Cardiovasc Pharmacol; 1991 Oct; 18(4):522-7. PubMed ID: 1724528
[TBL] [Abstract][Full Text] [Related]
33. Differential effects of the antianginal drug nicorandil on canine arteries and veins.
Morrison KJ; Flavahan NA; Vanhoutte PM
J Cardiovasc Pharmacol; 1990 May; 15(5):791-8. PubMed ID: 1692940
[TBL] [Abstract][Full Text] [Related]
34. Electrical responses of smooth muscle cells during cholinergic vasodilation in the rabbit saphenous artery.
Komori K; Suzuki H
Circ Res; 1987 Oct; 61(4):586-93. PubMed ID: 2820609
[TBL] [Abstract][Full Text] [Related]
35. Effects of 3-morpholinosydnonimine-N-ethylcarbamide on hypoxia-induced mechanical and electric responses of isolated pig coronary artery.
Yang XP; Wang FX; Ren DC; Lu SC; Fu SX; Li YS
Zhongguo Yao Li Xue Bao; 1995 Nov; 16(6):493-6. PubMed ID: 8732040
[TBL] [Abstract][Full Text] [Related]
36. Inorganic phosphate inhibits sympathetic neurotransmission in canine saphenous veins.
Edoute Y; Vanhoutte PM; Shepherd JT
Am J Physiol; 1987 Jan; 252(1 Pt 2):H131-4. PubMed ID: 3028159
[TBL] [Abstract][Full Text] [Related]
37. Effects of moderate acidosis on adrenergic neurotransmission in canine saphenous veins.
Verbeuren TJ; Janssens WJ; Vanhoutte PM
J Pharmacol Exp Ther; 1978 Jul; 206(1):105-14. PubMed ID: 207858
[No Abstract] [Full Text] [Related]
38. Endothelins and membrane potential of vascular smooth muscle of the canine coronary artery.
Nakashima M; Vanhoutte PM
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S229-31. PubMed ID: 7509952
[TBL] [Abstract][Full Text] [Related]
39. Pharmacology of pentoxifylline in isolated canine arteries and veins.
Hoeffner U; Aarhus LL; Katusic ZS; Vanhoutte PM
J Cardiovasc Pharmacol; 1989 Dec; 14(6):899-907. PubMed ID: 2481780
[TBL] [Abstract][Full Text] [Related]
40. Anisodamine antagonizes acetylcholine-induced inhibition of adrenergic neurotransmission in the canine saphenous vein.
Guo H; Lorenz RR; Vanhoutte PM
Chin Med Sci J; 1992 Mar; 7(1):32-5. PubMed ID: 1330075
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
